Dr. SP Shrivastava

AREA(S) OF INTEREST:

Chemotherapy, Hormonal therapies, Biological therapies, Targeted Therapy, Immunotherapy, Precision oncology and Bone Marrow Transplant.

PROCEDURES PERFORMED:

Autologous stem-cell transplant for Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, Multiple Myeloma, Neuroblastoma, Allogenic Stem Cell Transplant for Aplastic Anemia, AML, Induction and consolidation chemotherapies for ALL/AML, Perform central line insertion, PICC line insertion, Bone Marrow aspiration and biopsy, lumbar puncture, and intrathecal drug administration,Perform image-guided tru-cut biopsies, FNAC’s, pleural and peritoneal paracentesis.

TREATMENTS/PROCEDURES OFFERED:

Management of malignancies in patients with HIV/AIDS, Pioneer in the planning of RADIOSURGERY ( SRS, SBRT) in Central India, VMAT, IGRT, IMRT, 3DCRT, 2D RT on Triple energy Linear Accelerator (ELEKTA Synergy ) having kV based Cone Beam CT (CBCT), DMLC, SMLC and MONACO treatment planning system, Well experience in the planning like RAPID ARC, 2D RT on Dual-energy Linear Accelerator (ClinaciX, Varian) having kV-based Cone Beam CT (CBCT), 120 leaves DMLC, Eclipse Treatment Planning System, Well experience in planning 3CDRT, IMRT on Single energy Linear Accelerator (Siemens Primus), having ONCENTRA treatment planning system and EPID for imaging, Image Guided Brachytherapy (IGBT), Intraluminal and Interstitial Brachytherapy

NAME OF INSTITUTE(S):

• MBBS - NSCB Medical College, Jabalpur, MP, RDVV Jabalpur, MP (1995-2001)
• MD Radiation Oncology - NSCB Medical College, Jabalpur, MP, RDVV Jabalpur, MP (2002-2005)
• DM Medical Oncology - Sri Aurobindo Institute of Medical Sciences, Indore MP (2019-2022)
• European Society of Medical Oncology Certification (ESM0)-2021
• Professional Diploma in Clinical Research (PDCR) – 2020
• Certification in Palliative Cancer Care (IAPC)- 2012

• Associate Consultant- Department Of Medical & Radiation Oncology Max Hospital, New Delhi(March 2009 to December 2009)
• Senior Consultant - Department Of Medical & Radiation Oncology, Choithram Hospital and Research Centre, Indore(January 2010 to September 2015)
• Head and Senior Consultant Department Medical and Radiation Oncology, Shalby Hospital, Indore(September 2015 to September 2019)
• Head and Senior consultant Medical Oncology and Hemato Oncology, Shlaby Hospital Indore (oct 2022 to may 2024)

PUBLICATIONS

• (Original Article)Granulocyte Transfusion Therapy: Institutional experience of benefit in cancer patients with prolonged neutropenic sepsis: A retrospective study. Shiv Prasad Shrivastava (Corresponding Author), Aditya Elhence, Shweta Bhatnagar, Prutha Jinwala, Shashank Bansal, Prakash Chitalkar, Rajesh Patidar, Vikas Asati, Pradeep Kumar Reddy. Ind J Med Paediatr Oncol 2022;00:1–6. DOI: 10.1055/s-0042-1757730. ISSN 0971-5851.
• (Original Article) Assessment of Psychological and Physical Distress among Indian Adolescents and Young Adults with Solid Cancer Using the NCCN Distress Thermometer and Rotterdam Symptom Checklist. Shiv Prasad Shrivastava (Corresponding Author), Aditya Elhence, Shweta Bhatnagar, Prutha Jinwala, Shashank Bansal, Prakash Chitalkar, Rajesh Patidar, Vikas Asati, Pradeep Kumar Reddy. J CurrOncol 2022;5:25-34. DOI: 10.4103/jco.jco_2_22, 2022, Journal of Current Oncology.
• (Original Article)Assessment of Psychological distress among Indian adolescents and Young adults with solid cancer using the National Comprehensive Cancer Network (NCCN) distress thermometer. Shiv Prasad Shrivastava (Corresponding Author), Aditya Elhence, Shweta Bhatnagar, PruthaJinwala, Shashank Bansal, Prakash Chitalkar, , Rajesh Patidar, Vikas Asati, Pradeep Kumar Reddy. South Asian Journal Of Cancer (SAJC). South Asian J Cancer 2022;00(00): 1–7. DOI https://doi.org/10.1055/s-0042-1756184 ISSN 2278-330X
• A Rare Case of Life-Threatening Extensive Mucocutaneous Adverse Reaction Induced by Docetaxel in a Breast Cancer Patient: Toxic Epidermal Necrolysis, a Case Report with Review of Literature. Shiv Prasad Shrivastava (Corresponding Author), Aditya Elhence, Prutha Jinwala, Shashank Bansal, Prakash Chitalkar, Shweta Bhatnagar, Rajesh Patidar, VikasAsati. Ind J Med PaediatrOncol, DOI https://doi.org/10.1055/s-0042-1743125. ISSN 0971-5851.
• The Impact of COVID-19 Pandemic on Cancer Care in a Tertiary Care Facility Pradeep Kumar Reddy K, Jyosthna Elagandula, Shivani Patel, Rajesh Patidar, VikasAsati, Shiv Prasad Shrivastava, Aditya Elhence, Runu Sharma, B. S. Ankit, Prakash G. Chitalkar. South Asian J Cancer 2021;10:32–35.
• A Rare case of B Lymphoblastic Lymphoma presenting as Acute onset paraparesis- Case Report, Hematology, Transfusion and Cell Therapy (2022), Aditya Elhence, Shiv Prasad Shrivastava, Prutha Jinwala, Shashank Bansal, Prakash Chitalkar, Shweta Bhatnagar, Rajesh Patidar, VikasAsati, https://doi.org/10.1016/j.htct.2022.06.002
• Initial Experiences in Adolescents and Young Adults with T-Cell Acute Lymphoblastic Leukemia/Lymphoma Treated with the Modified BFM 2002 Protocol in a Resource-Constrained Setting. SP Shrivastava, PruthaJinwala, Rajesh Patidar, Shashank Bansal, VikasAsati, Aditya Elhence, Swati Patel P.G. Chitalkar. South Asian J Cancer 2023;00(00):00–00. DOI https://doi.org/10.1055/s-0043-1776040 ISSN 2278-330X
• Assessment of Knowledge about Palliative Care among Registered Nursing Professionals: A Prospective Cross-Sectional Study in a Tertiary Care Hospital in Central India, SP Shrivastava, Shashank Bansal, Prutha Jinwala, Vikas Asati, Sudharani B Banappagoudar, Aditya Elhence, Rajesh Patidar, Pankaj Singhai, Swati Patel, P.G. Chitalkar, Asian Pac J Cancer Care, 8 (4), 709-713, DOI:10.31557/APJCC.2023.8.4.709

POSTERS & ABSTRACTS

• Iron deficiency anemia and thrombocytopenia a rare manifestation of Carcinoma prostate: a case report, ISMPCON 2022. Shiv Prasad Shrivastava, Aditya Elhence, Shashank Bansal, PruthaJinwala, VikasAsati, Rajesh Patidar, Prakash Chitalkar Department of Medical Oncology, Sri Aurobindo Institute of Medical Sciences, Indore MP.
• Pancytopenia and eosinophilic infiltration of liver and lung mimicking metastasis: A rare case presentation , ISMPCON 2022. Shiv Prasad Shrivastava, Aditya Elhence, Shashank Bansal, PruthaJinwala, VikasAsati, Rajesh Patidar, Prakash Chitalkar Department of Medical Oncology, Sri Aurobindo Institute of Medical Sciences, Indore MP
• Assessment of Physical and Psychological Distress among Adolescents and Young Adults with Cancer using the NCCN Distress Thermometer ISMPCON 2022. Shiv Prasad Shrivastava, Aditya Elhence, Shashank Bansal, PruthaJinwala, VikasAsati, Rajesh Patidar, Prakash Chitalkar Department of Medical Oncology, Sri Aurobindo Institute of Medical Sciences, Indore MP
• The voice of young persons with cancer finds utterance: culture-specific counselling makes a difference (Abstract in 4th Global Adolescent and Young Oncology (AYA) Cancer Congress, 2021)

PRESENTATIONS

• The origin an devolution of metastatic Urothelial cell carcinoma
• Place of Polatuzumab in the management of NHL Evolving Trends in management of HER-2 positive mBC
• Unleashing HOPE: Redefining survival outcomes with Dual ICI’s
• Dilemma of Choosing a CDK4/6i in 1L mBC Setting – Reality or Myth?
• Redefining the management of NSCLC with Atezolizumab - Now and next
• Daratumumab in multiple Myeloma: a paradigm shift
• Case based panel discussion on optimizing treatment outcomes in Hodgkins lymphoma
• Adjuvant treatment for triple positive BRCA positive LABC
• Optimizing Patient Outcomes in Head and Neck Cancers: An overview of Targeted Therapies
• TOPAZ 1: Metastatic Gall Bladder carcinoma
• Newer updates of immunotherapy in ES-SCLC
• Osimertinib real world evidence as first line therapy in mNSCLC
• Evolving trends in management of HER 2 positive mBC
• Newer updates in the management of 1st Line in BTC
• Role of Gardasil 9 in prevention of multiple cancers
• Biomarkers in oncology
• Optimizing treatment decisions in Unresectable Stage III NSCLC: A Case Study
• Unraveling the Path of HER2+ Breast Cancer in next 2 Years – Indian Context
• Atezolizumab plus chemotherapy and bevacizumab in 1line non-squamous mnsclc - IMpower150
• What and what you must know about cancer
• Role of IHC and NGS in oncology
• Tumor markers and its utility in oncology
• Choice of CDK 4/6 in MBC is cost or OS the deciding factor
• Cancer awareness meeting in hinterland of Madhya Pradesh dec 2023
• Shingerix vaccine in elderly cancer patients Oct 2023
• Pembrolizumab and Solid tumors Oct 2023
• Role of Immunotherapy in R/R Head and Neck Cancer Sept 2023
• Lung Update: management of stage 4 NSCLC Aug 2023
• Management of Her2 positive metastatic breast cancer July 2023
• CDK 4/6 Inhibitors in HR +ve and Her 2 negative breast cancer in an update in breast cancer Feb 2023.
• Management updates in metastatic Lung cancer: role of driver mutation based therapy and results, Feb 2023
• Role of PARP Inhibitors in Ovarian Cancer Jan 2023
• Distress Thermometer: use in cancer patients. May 2022
• Radiosurgery in Brain tumors: Past, present and future April 2022
• Acute Myeloid Leukemia: updates Dec 2021
• Management of immunotherapy-related adverse events Sept 2021
• Granulocyte Transfusion Therapy: Process and role in indications July 2021
• Carcinoma Colon management updates March 2021
• Gastroesophageal Cancer: role of Nivolumab Nov 2020
• Renal cell carcinoma: role of immunotherapy August 2020
• Triple Negative breast cancer management Jan 2021
• Primary study endpoint analysis for NRG oncology/RTOG 0813 trial of Stereotactic
• Body Radiotherapy (SBRT) for centrally located non-small cell lung cancer (NSCLC). Abstract presentation in International Conference 2nd Best of ASTRO 2016 at Gurgaon.
• Initial Results of a Phase III Randomized Study of High Dose 3DCRT/ IMRT versus Standard Dose 3D-CRT/IMRT in men with Localized Prostate Cancer. Abstract presentation in International Conference 1st Best of ASTRO 2015 at Mumbai.
• Case presentation on Radiation planning in case of Carcinoma breast with ICD (Implantable cardioverter-defibrillators ) at Indore Oncology Forum 2014.
• Case Presentation on Radiation Planning of Medulloblastoma with simultaneous suprasellar metastasis, a rare case, in Neuro-oncology Club, Indore. 2013
• Dosimetric comparison, IMRT vs 3DCRT in Carcinoma Esophagus. Scientific paper in 15th annual conference of Northern Chapter of AROI ( Association Of Radiation oncology of India ) held on 3rd and 4th October 2009, Delhi.

OVERSEAS PARTICIPATIONS

• European Lung Cancer Congress (ELCC), Geneva, Switzerland 2019.
• European Society Of Medical Oncology (ESMO) meeting , Munich, Germany 2018.
• European Society Of Medical Oncology (ESMO) Asia meeting, Singapore 2017.
• 4.As a Panelist: Adjuvant therapy in Lung cancer in T2 tumors and Neo-Adjuvant Therapy in Localized Lung Cancer in Lung Cancer session at UAE Cancer Congress ( 8th Edition, International Conference ) Dubai, UAE
• 5.54th Annual Meeting of ASTRO (American Society for Radiation Oncology), held at Boston, MA. USA from 28th – 31 October 2012.
• 6.PT 107-2009-01 Study India Investigators Meeting held on 9th – 11th October at Pattaya, Thailand as Principal Investigator.

PROFESSIONAL MEMBERSHIP

• European Society Of Medical Oncology (ESMO)
• Indian Society of Medical and Paediatric Oncology (ISMPO)
• Teenage and Young Adult Cancer Foundation (TYAcan)
• Association of Radiation Oncology of India (AROI)
• Indian Cooperative Oncology Network (ICON)